A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of AMG 334 in Migraine Prevention (ARISE-Study)
01.06.2015
To evaluate the effect of AMG 334 compared to placebo on the change from baseline in monthly migraine days, in subjects with episodic migraine
Klinische Forschung -
01.06.2015 - 31.12.2017
Automatisch geschlossen
Projektleitung: Flügel Dominique
Mitarbeiter/innen: Zieglgänsberger Dominik, Müller Anna
Weiter